Immunodeficiency common variable and Infusion site swelling

Summary:

Infusion site swelling is found among people with Immunodeficiency common variable, especially for people who are female, 60+ old.

The study analyzes which people have Infusion site swelling with Immunodeficiency common variable. It is created by eHealthMe based on reports of 1,399 people who have Immunodeficiency common variable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Immunodeficiency common variable?

Immunodeficiency common variable is found to be associated with 86 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.

What is Infusion site swelling?

Infusion site swelling is found to be associated with 579 drugs and 359 conditions by eHealthMe. Check the latest studies of Infusion site swelling.

On Jul, 08, 2026

1,399 people who have Immunodeficiency Common Variable and Infusion Site Swelling are studied.

Would you have Infusion site swelling when you have Immunodeficiency common variable?

Gender of people who have Immunodeficiency common variable and experienced Infusion site swelling *:

Click here to view

Age of people who have Immunodeficiency common variable and experienced Infusion site swelling *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Infusion site swelling?

- Check whether Infusion site swelling is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Immunodeficiency common variable (31,613 reports)
Infusion site swelling (6,559 reports)

All the drugs that are associated with Infusion site swelling:

Infusion site swelling (579 drugs)

All the conditions that are associated with Infusion site swelling:

Infusion site swelling (359 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Infusion site swelling and Immunodeficiency common variable, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.